BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Phathom Pharmaceuticals Mourns the Loss of Chairman and Founder, Tadataka “Tachi” Yamada, M.D.

  Phathom Pharmaceuticals, Inc. announced today the sad news that its chairman and founder, Dr. Tachi Yamada, passed away suddenly at his Seattle, Washington home on August 4.

  August 5, 2021

   · 

  1 min read
• Business

  KemPharm to Report Second Quarter 2021 Results

  KemPharm today announced the Company will host a Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, August 12, 2021, 4:30 p.m. ET

  August 5, 2021

   · 

  2 min read
• Business

  BridgeBio Pharma, Inc. Reports Second Quarter 2021 Financial Results and Business Update

  BridgeBio Pharma, Inc. today reported its financial results for the second quarter ended June 30, 2021 and provided an update on the Company’s operations.

  August 5, 2021

   · 

  15 min read
• Deals

  Cytocom Inc. Provides Update on Completed Merger with Cleveland BioLabs

  Cytocom Inc. today provided shareholders with an update regarding its recent merger with Cleveland BioLabs.

  August 5, 2021

   · 

  7 min read
• Business

  Syros Reports Second Quarter 2021 Financial Results and Highlights Key Accomplishments and Upcoming Milestones

  Syros Pharmaceuticals today reported financial results for the quarter ended June 30, 2021, and provided an update on recent accomplishments and upcoming events.

  August 5, 2021

   · 

  11 min read
• Genetown

  TransCode Therapeutics Awarded Funding from National Institutes of Health (NIH) to Support Clinical Evaluation of TTX-MC138

  TransCode Therapeutics, Inc. today announced that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant from the NIH to support the clinical evaluation of TTX-MC138, TransCode’s lead therapeutic candidate for the treatment of metastatic solid tumors.

  August 5, 2021

   · 

  4 min read
• Genetown

  Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability

  Pressure BioSciences, Inc. today announced major aggressive goals for the second half of 2021.

  August 5, 2021

   · 

  7 min read
• Business

  Novan to Report Second Quarter 2021 Financial Results on August 12, 2021

  Novan, Inc., announced that it will report its second quarter 2021 financial results on Thursday, August 12th.

  August 5, 2021

   · 

  1 min read
• Business

  Protara Therapeutics Announces Second Quarter 2021 Financial Results and Business Overview

  Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, announced financial results for the second quarter ended June 30, 2021 and provided a business update.

  August 5, 2021

   · 

  11 min read
• Policy

  Apexigen Receives Orphan Drug Designation from the FDA for Sotigalimab (APX005M) for the Treatment of Soft Tissue Sarcoma

  Apexigen, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing a new generation of antibody therapeutics for oncology, announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to sotigalimab for the treatment of soft tissue sarcoma.

  August 5, 2021

   · 

  3 min read